Tethered Ligands that Target the µ-Opioid Receptor Design and Synthesis of Novel GPR139 Agonists with Therapeutic

Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces

When “inhibition” becomes activation—and how that insight fuels next-gen therapeutic design.

implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic

indicated by the fact that about 40% of all drugs currently used in clinical practice mediate their therapeutic

Hopkins, Exscientia’s founder and CEO was elected a Fellow of the Academy of Medical Sciences Structure Therapeutics

Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics

advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic

cognate positions across GPCR paralogs opens a window into cancer mechanisms and potential approaches to therapeutics

They offer extraordinary therapeutic promise —but their complexity makes them one of the hardest targets

Kenakin highlights that therapeutic efficacy depends on the period during which a drug is actively engaged

A strong preclinical signal opens adjacent therapeutic areas.

Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics

the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics

GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet

M. et al. 2019), and hydrogen-deuterium exchange (HDX) mass spectrometry for time-dependent conformational within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic

competitive edge:  Learn to leverage restricted diffusion and rebinding to create drugs with longer therapeutic

4️⃣ Comparative value: Have you positioned your therapeutic against the right standard or competitor,

way for understanding the CBD pharmacology at a molecular level and aid in harnessing its potential therapeutic

potential use of Opn5 and its homologs Industry News The Leading GPCR Company in Immuno-Oncology, Domain Therapeutics

Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics

revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively activate therapeutically analyzing drug-target interactions and disease pathways, AI can identify potential candidates that may have therapeutic

Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic

Essential Frameworks for Precision Drug Discovery: An Insight into Advanced Strategies for Targeted Therapeutics

understanding how serotonin receptors, one of the largest subfamilies of class A GPCRs and potential therapeutic

Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research collaborations GPCR Therapeutics

Introduction to Adenosine Receptors as Therapeutic Targets.

Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024 Domain Therapeutics

increasingly depend on those who can unite modeling with experimentation, turning predictions into real therapeutic

MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic